the question still remains....

At the risk of raining on this parade.....the question I asked a long time ago and still continue to ask is still valid.....

What are the implications for the BTT and DT trials with this new "development"???

It's clear to me that they are hinting towards TETS technology (removing the dependency on the battery pack)....But will the FDA accept this "alteration" to the device or will they request a new set of trials??....

This is NOT the time for inovation, it's the time for profit and return on investments.......

If this "development" will not expedite returns or contribute to the bottom line financial situation of the company, then, IMO ONLY, the market will view it as worthless for the immediate future. IMO ONLY, the market wants to see revenue, not to mention (at very least) improved sp actions. Having yet another alteration to the device, is just that, if it will not result in financial benefits.

Cheers